BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign ...

t (Duration of Full-Power Continuous Discharge): Refers to the total duration an energy storage station can discharge continuously at its rated power until its energy is depleted. It is determined by ...

Defining precisely where drugs engage their targets in vivo is essential for understanding efficacy and toxicity. However, mapping in vivo drug targets with spatial and cellular resolution remains ...

By Priyanjana Pramanik, MSc. A controlled crossover trial finds that short-term consumption of unprocessed beef is on par ...

A novel four-protein biomarker blood panel promotes early pancreatic cancer detection, identifying 91.9% of cancer cases and surpassing standard tests.

If you build it, they will come.

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the submission of the final module of the Premarket Approval (PMA) ...

This cat was born looking permanently unimpressed. Thanks to some wild fur markings, this cat appears to have thick eyebrows ...

Bacteria incubated with bacteriophages in space accumulated distinct mutations compared to those on Earth, highlighting the ...